Loading
Singapore Institute of Advanced Medicine Holdings Ltd. Stock: price and insider trades · Singapore
No insider purchase over the last 90 days. The latest, by Caterine Limited ("Caterine"), was filed 20 Oct 2025.
Singapore Institute of Advanced Medicine Holdings Ltd.: what insiders have been doing
Singapore Institute of Advanced Medicine Holdings Ltd., classified in the Health Care sector, is a listed company. Its insiders report their share dealings to SGX. Between 22 October 2025 and 22 October 2026, 1 insider published 20 filings.
No open-market purchase or sale appears among the filings, only grants, plan transactions and other operations. Compensation-driven entries like these are tracked, but they say little about how insiders judge the share price.
Across the 394 companies tracked on its exchange, the median is 6 filings; at 20 filings, this issuer sits above that mark. Looking back to 2024, when coverage begins, insiders filed 10 purchases and no sales.
No insider has bought Singapore Institute of Advanced Medicine Holdings Ltd. shares on the open market in the past twelve months.
Every figure here comes from the filings published by SGX and describes the past, not future prices; it is not investment advice.
Insider Decl.
38
Thresholds
n/a
Buy Volume
€6M
10 ops. · all time
Sell Volume
n/a
n/a
Who traded when
BuySaleCaterine Limited ("Caterine")1 buy
Since the insiders bought
- +68.6%Entry SGD 0.04 · Close at T+90 SGD 0.06
- -51.4%Entry SGD 0.10 · Close at T+365 SGD 0.05
- -51.4%Entry SGD 0.10 · Close at T+365 SGD 0.05
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Fundamental score
Ranked 20,964 of 26,280 companies
30.8
score / 100
Value10
Quality52
FCF yld-11%
Earn yld-63%
EV/EBITDA·
ROE-44%
Gross mgn92%
Net mgn·
Debt/EBITDA·
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Financial data
as of FY 2026FY ended June 2026 · cache
SGD 0.02
Analyst consensus
Income statement
RevenueSGD 15.7M
Gross profitSGD 14.5M92% margin
EBITDA-SGD 9M-57% margin
Net income-SGD 23.9M-152.0% margin
Valuation
P/Book0.7x
Beta-0.07
Balance sheet & cash
Market capSGD 37.9M
Total debtSGD 61.3M
Free Cash Flow-SGD 4.1M
Debt / Equity116%
Profitability & ownership
ROE-44.0%
ROA-9.6%
% insiders65.0%
% institutions1.6%
Last declaration on 1 July 2026
Declarations38 total
ShareSGX-STSGX:RGGVNY0F2JS6DW5I
ShareSGX-STSGX:ME4ZT2J0SBEETEBM
ShareSGX-STSGX:8Q53PXODRYHAP191
ShareSGX-STSGX:WE1VGMBDRHDTRDBJ
ShareSGX-STSGX:2D91T7GFGL16AOA9
ShareSGX-STSGX:XGIXDGNAFL39AA2B
ShareSGX-STSGX:J1FHR3WLKRWHS50P
ShareSGX-STSGX:2NQ8KQRZ0874ABWF
ShareSGX-STSGX:P9TIISTLOFPY002V
ShareSGX-STSGX:SNIZDJ4L0VHLWHFL
ShareSGX-STSGX:VR3R036BMLT15PS9
ShareSGX-STSGX:OMK1ZRYVHETYTJ6X
ShareSGX-STSGX:GBF4LFD33KX0JI6C
ShareSGX-STSGX:I2LPB5TO3RLDNLU1
ShareSGX-STSGX:YS9FK3LA419OD387
ShareSGX-STSGX:E6O70O9GKJ9DYRLX
ShareSGX-STSGX:J4D80UK0AIRFURIF
ShareSGX-STSGX:10PQQ66YZOHPXX5R
ShareSGX-STSGX:WCVXJMGK52CST1QO
ShareSGX-STSGX:N7I9BEI10VHC4H9U
149,726,000 shares@ SGD 0.035100.0% of flowShareSGX-STISIN SGXE79544776SGX:V09A4RGFRI2KEFF5
Canonical exit: 13 Jan 2026 (T+90)
ShareSGX-STISIN SGXE79544776SGX:5TO8JITLAW0X6HXJ
ShareSGX-STISIN SGXE79544776SGX:663Z2OR1SU7ZWDEV
ShareSGX-STISIN SGXE79544776SGX:HUPISX0MW1DV2K1V
ShareSGX-STISIN SGXE79544776SGX:NWUZT4WXBLHZ0LQ1
25 of 38 declarations
About Singapore Institute of Advanced Medicine Holdings Ltd.
Singapore Institute of Advanced Medicine Holdings Ltd. is a Singapore-based company focused on the development and commercialization of advanced medical solutions. It primarily operates in the healthcare market.
